Free Shipping on purchases over €100

DS Advanced CBD Hyaluronic, 30 ml

DS Advanced CBD Hyaluronic, 30 ml

DS Advanced CBD Hyaluronic, 30 ml is a serum that combines a multi-molecular complex of 10 forms of hyaluronic acid with broad-spectrum CBD and provides the skin with different levels of subcutaneous to surface hydration.

SKU: DS0816378022090
-19%
Promo FD
53.01
€65.07
€176.70
/100ml

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

DS Advanced CBD Hyaluronic in its 30 ml presentation is a serum that has been exclusively formulated on the basis of broad-spectrum CBD that is combined with a multi-molecular complex of 10 forms of hyaluronic acid and provides the skin with sufficient hydration at different subcutaneous levels.

On the one hand, broad-spectrum CBD hydrates the skin and increases its elasticity, while improving its appearance, thanks to its high content of Omega 6 and Omega 3, which help to regulate the immune system and promote healthier skin. Thanks to its moisturising mechanism, the skin begins to look smoother, more even and firmer; it also helps to fill in wrinkles in the skin, giving them a tightening effect.

Its formula has been tested by dermatologists who have confirmed its powerful action in preventing the appearance of wrinkles. Its antioxidant effect slows down expression lines and cellular ageing, while improving the skin's firmness and elasticity. It is also a product that increases the skin's hyaluronic acid levels, ensuring optimal levels of hydration, reducing wrinkles and furrows and stimulating collagen production, restoring skin firmness. Finally, it improves skin texture because it does not contain perfumes, silicone, parabens, gluten or hydroquinone.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.